ADMA vs ALMS Stock Comparison

ADMA currently leads ALMS in this stock comparison, with AIQ scores of 78 vs 20. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 58 points
ADMA
Healthcare
vs
ALMS
Healthcare
ADMA
ADMA Biologics, Inc.
Leads
Price
$13.68
Day move
+3.32%
AIQ Score
78/100
Best edge
Momentum
Sector
Healthcare
ALMS
Alumis Inc.
Price
$5.60
Day move
-8.65%
AIQ Score
20/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between ADMA and ALMS?

ADMA leads the current stock comparison as ADMA Biologics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

ADMA Biologics, Inc. vs Alumis Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

ADMA leads

ADMA leads by 58 AIQ points, primarily on Momentum and Quality, and the lead has widened from 47 points over 30 sessions. Wall Street currently favors ALMS on target upside.

Stable: 4 of 5 evidence groups support ADMA, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 5Comparison trend: Strengthening
ADMA

ADMA Biologics, Inc.

Leads
AIQ Score
78/100
AIQ Edge Score
10/10
ALMS

Alumis Inc.

AIQ Score
20/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors ADMA over ALMS, 78 versus 20 as of Nov 15, 2026. ADMA's advantage is driven primarily by stronger momentum and quality. ADMA also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ALMS. 4 of 5 covered evidence groups favor ADMA today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. ADMA lead: Strengthening — the AIQ differential moved from 47 to 58 points over 30 sessions.

Compare ADMA Biologics, Inc. and Alumis Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ADMA
+22.4%
ALMS
-57.9%

Price return comparison

Growth of $10,000, price only

ADMA $12,236 · ALMS $4,211

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ADMA and ALMS against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ADMA advantage
0
ALMS advantage
  • Momentum91 vs 13
    ADMA +78
  • Quality72 vs 29
    ADMA +43
  • Risk Resilience56 vs 20
    ADMA +36

4 of 5 evidence groups favor ADMA. ADMA’s edge is concentrated in momentum and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ADMA0 AIQ

No factor moved materially.

New signals

  • RSI Overbought — bearish, momentum, short horizon
ALMS-1 AIQ

Largest factor move: Quality -2

New signals

  • BB Lower Band Breach — bullish, volatility, short horizon

ADMA's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — ADMA and ALMS both carry a full feed there.

The central trade-off

ADMA (ADMA Biologics, Inc.): the stronger current systematic profile, led by momentum and quality.

ALMS (Alumis Inc.): the counter-case, on analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ADMA

ADMA on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

ALMS

ALMS on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

ADMA

ADMA on the Momentum factor, by 78 points.

Lower downside

ADMA

ADMA on Risk Resilience, by 36 points.

Analyst upside

ALMS

ALMS on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ADMA, analyst targets favor ALMS. That disagreement is the most useful thing on this page.

MeasureADMAALMSNote
Implied upside to target+31.6%+375%ALMS has more room
Target dispersion0%+82.7%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering410Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 5 covered evidence groups favor ADMA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreADMA78 vs 20
FundamentalsADMAon balancerevenue growth 13.4% vs 14.7%; EPS growth 29.4% vs 34.2%; TTM ROE 11.4% vs -25.1%; gross margin 68.5% vs -13.1%; operating margin 44.9% vs -61.2% — ADMA takes 3 of 5 decided legs, not all of them
ValuationNot coveredNot covered
TechnicalsADMAPrice vs 50-day 29.4% vs -22.7%; vs 200-day 27.6% vs -72.6%
Risk ResilienceADMARisk Resilience 56 vs 20
Analyst expectationsALMSTarget upside 31.6% vs 375%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ADMA and ALMS and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 58 points. (supports the conclusion holding)
  • 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ADMA.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ADMA lead: Strengthening — the AIQ differential moved from 47 to 58 points over 30 sessions.

May 27ADMA leads above the line · ALMS leads belowNov 13
Today
ADMA +58
78 vs 20
7 sessions ago
ADMA +56
77 vs 21
30 sessions ago
ADMA +47
69 vs 22
90 sessions ago
ADMA +10
56 vs 46

The lead changed hands once in this window, most recently on Aug 4 when ADMA moved ahead of ALMS.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ADMAConflicted

3 bullish / 2 bearish / 2 neutral, conflicted

Only ADMA

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • RSI Overbought — bearish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
ALMSConflicted

1 bullish / 3 bearish / 1 neutral, conflicted

Only ALMS

  • BB Lower Band Breach — bullish, volatility, short horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Downtrend Structure Active — bearish, trend, long horizon

Both carry 2 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode.

ADMA leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ADMANo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +3.32%, AIQ 0 points).

ALMSConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -8.65%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ALMS closes the Momentum gap — currently 78 points behind, the largest single contributor to ADMA's edge.
  2. 2ALMS's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3ADMA's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ADMA leads on balance
MetricADMAALMS
Revenue growth (YoY)13.4%14.7%
EPS growth (YoY)29.4%34.2%
Gross margin68.5%-13.1%
Operating margin44.9%-61.2%
Return on equity (TTM)11.4%-25.1%
Debt to equity0.460.09

Performance

ADMA leads 5 of 6 windows
MetricADMAALMS
1 week (5 sessions)7.5%-7.1%
1 month (20 sessions)28.1%-8.5%
3 months (63 sessions)46.5%-78%
6 months (126 sessions)65.4%-75.5%
Year to date-25%-42.6%
1 year (252 sessions)-16.9%6.9%

Technicals

ADMA has the stronger structure
MetricADMAALMS
RSI (14)7134
ADX (14)3440.5
Price vs 50-day29.4%-22.7%
Price vs 200-day27.6%-72.6%
Volatility (1M, annualized)102.3%82.5%

Risk

ADMA is the more resilient
MetricADMAALMS
Beta-0.091.98
Sharpe ratio-0.010.65
Sortino ratio-0.011.17
Max drawdown-62.7%-81.5%
Current drawdown-32.9%-81.5%
Annualized volatility58.9%137.6%
Value at risk (95%)-4.3%-7.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ADMA or ALMS?

On the Algovestiq AIQ Score, ADMA is the stronger of the two as of Nov 15, 2026, scoring 78 against ALMS's 20. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ADMA or ALMS the better buy right now?

ADMA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor ADMA over ALMS?

The composite weights Quality, Value, Momentum and Risk Resilience. ADMA leads Momentum by 78 points; ADMA leads Quality by 43 points; ADMA leads Risk Resilience by 36 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ADMA or ALMS?

Analyst price targets imply +31.6% upside for ADMA and +375% for ALMS, so the Street currently favors ALMS. That points the opposite way to the AIQ Score, which favors ADMA. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ADMA or ALMS?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ADMA or ALMS?

ALMS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ADMA or ALMS?

ADMA on the Momentum factor, by 78 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ADMA or ALMS?

ADMA is the more resilient of the two, so the other name carries the higher downside risk. ADMA on Risk Resilience, by 36 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ADMA more profitable than ALMS?

ADMA leads on the comparable margin measures — gross margin 68.5% vs -13.1%; operating margin 44.9% vs -61.2%; ttm roe 11.4% vs -25.1%.

Is ADMA's lead over ALMS getting stronger or weaker?

ADMA lead: Strengthening — the AIQ differential moved from 47 to 58 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-08-04, when ADMA moved ahead of ALMS.

What would change the ADMA vs ALMS verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ALMS closes the Momentum gap — currently 78 points behind, the largest single contributor to ADMA's edge; ALMS's Death Cross Active resolves — a bearish trend rule currently active against it; ADMA's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ADMA and ALMS?

ADMA: 3 bullish / 2 bearish / 2 neutral, conflicted. ALMS: 1 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ADMA is Death Cross Active (bearish, long horizon). On ALMS it is Death Cross Active (bearish, long horizon).

Compare ADMA and ALMS with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.